Oncology PracticeThe ‘great dynamism’ of radiation oncologyAugust 18, 2022Lung CancerMixed TopicsBreast CancerHead & Neck/Thyroid CancersGenitourinary Cancer
Oncology PracticeGetting cancer research on track again may require a ‘behemoth’ effortAugust 15, 2022Mixed TopicsBusiness of MedicineBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Oncology PracticeGenetic counseling for cancer often costs patients nothingAugust 9, 2022Patient & Survivor CareBreast CancerPreventive Care
Oncology PracticeFDA approves trastuzumab-deruxtecan for HER2-low breast cancerAugust 5, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeNode-negative triple-negative breast cancer prognosis lies within stromal lymphocytesAugust 2, 2022Metastatic Breast CancerBreast Cancer
Commentary: Looking at Therapies for Patients With HER2-low Breast Cancer, August 2022July 29, 2022Breast Cancer
Oncology PracticeLife and death decisions: What keeps oncologists up at nightJuly 28, 2022Metastatic Breast CancerMixed TopicsBreast CancerCLL
TNBC: Meta-analysis recommends lower dosage and higher frequency of capecitabine in the adjuvant settingJuly 27, 2022Breast Cancer
No prognostic impact of PMRT in pT1-2 BC tumors with N1 lymph node metastasesJuly 27, 2022Breast Cancer
